Protecting the legal supply chain of medicines in Europe against counterfeit drugs.
Initiated by International Institute of Research Against Counterfeit Medicines (IRACM) with the support of the European Commission, the Pharmacrime 3 conference was held on March 26 and 27 at the Interpol headquarters in Lyon to finalize an essential European project in the fight against counterfeit medicines.
The conference, attended by healthcare experts, police and customs officers from 27 European countries, aimed to step up the effectiveness of investigations related to the trafficking of counterfeit medicines. It should help to standardize practices to facilitate international legal coordination.
Around 100 experts from the European Union finalized the Practical Guide for EU Investigations on Falsified Medicines, which was then distributed to investigators in EU countries from June 2014.
Given the success of the first two phases of Pharmacrime, which were devoted to sharing best practices in addressing the trafficking of counterfeit medicines and methods to fight internet trafficking, IRACM and its partners launched this new tool to deal with the introduction of counterfeit medicines into the legal European medicine supply chain.
The specific goal of Pharmacrime 3 was to issue a practical guide to those investigating criminal groups attempting to introduce falsified medicines into the legal supply chain. The conference received financial support from the European Commission and International Institute of Research Against Counterfeit Medicines (IRACM).
Several partners including IRACM worked together for months on this project. A European workshop was attended by 25 experts near Paris in January 2014 and a two-day conference was held to review and adapt the guide to the potential needs of EU investigators.
The project began in May 2013 and was completed in July 2014. The European Investigation guide was published and translated into 12 EU languages. It was distributed to all relevant EU authorities in June 2014.
The conference was funded by the European Commission and International Institute of Research Against Counterfeit Medicines (IRACM), and was organized by Eucojust [lien vers www.eucojust.org] (Association for European Cooperation on Justice and Home Affairs).
Partners involved in Pharmacrime 3
- INTERPOL (International Criminal Police Organisation),
- IRACM (International Institute of Research Against Counterfeit Medicines),
- IMB (Irish Medicines Board),
- MHRA (Medicines and Healthcare products Regulatory Agency),
- OCLAESP (Office Central de Lutte contre les atteintes à l’environnement et à la Santé Publique – French Gendarmerie),
- PFIPC (Permanent Forum on International Pharmaceutical Crime),
- PSI (Pharmaceutical Security Institute).
• See press release “Pharmacrime 3: At the initiative of IRACM and the European Commission, the experts of 27 European States in the fight against falsified medicines gather at Interpol headquarters in Lyon.”.
• Find out more about Pharmacrime 3.